Predictors of mortality post-gastrostomy in motor neuron disease patients

被引:2
作者
Yang, Jie [1 ,2 ]
Zhao, Yun [1 ]
Soares, Mario [1 ]
Needham, Merrilee [3 ,4 ,5 ]
Begley, Andrea [1 ]
Calton, Emily [1 ,6 ,7 ]
机构
[1] Curtin Univ, Fac Hlth Sci, Curtin Sch Populat Hlth, Kent St, Perth, WA 6102, Australia
[2] Fiona Stanley Hosp, Dept Nutr & Dietet, Perth, WA, Australia
[3] Fiona Stanley Hosp, Dept Neurol, Perth, WA, Australia
[4] Univ Notre Dame, Fac Med, Perth, WA, Australia
[5] Murdoch Univ, Ctr Mol Med & Innovat Therapeut CMMIT, Perth, WA, Australia
[6] Curtin Univ, Fac Hlth Sci, Sch Allied Hlth, Perth, WA, Australia
[7] Harry Perkins Inst, South Metropolitan Hlth Serv, Murdoch, WA, Australia
关键词
gastrostomy; motor neuron disease; predictor; short survival; weight; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; AMYOTROPHIC-LATERAL-SCLEROSIS; SURVIVAL; ALS;
D O I
10.1002/mus.28245
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction/AimsMotor neuron disease (MND) is a progressive neurodegenerative condition with a limited life expectancy. There is very little data on mortality and its associated factors beyond 30 days following gastrostomy. We explored the demographic, clinical, and nutritional predictors for early mortality at 30, 90, and 180 days following gastrostomy in these patients.MethodsThis was a retrospective study involving 94 MND patients in Western Australia who underwent gastrostomy between 2015 and 2021. Patients were divided into two groups based on mortality at 30, 90, and 180 days post-gastrostomy. T-test (or Mann-Whitney), chi-square test and Fisher's exact test were used for detecting between-group differences in various factors. Multivariable logistic regression was used to identify factors associated with post-gastrostomy mortality at 90 and 180 days.ResultsNo mortality was attributable to gastrostomy-related complications. Lower forced vital capacity (FVC) (p = .039) and greater weight loss (%) (p = .022) from diagnosis to gastrostomy were observed in those who died within 30 days post-gastrostomy. Older age (p = .022), male sex (p = .041), lower FVC (p = .04), requiring but not tolerating noninvasive ventilation (p = .035), and greater weight loss (%) (p = .012) were independent predictors of 90-day post-gastrostomy mortality. However, only older age (p = .01) and greater weight loss (p = .009) were predictors of mortality at 180 days post-gastrostomy.DiscussionOur data indicated that mortality at 90 and 180 days was influenced by the weight loss (%) from diagnosis to gastrostomy, highlighting the importance of nutritional care in the MND population. Gastrostomy placement prior to substantial weight loss may reduce the risk of weight loss-associated mortality and warrants further investigation. This retrospective study explored the factors associated with mortality in MND patients at 30, 90, and 180 days post-gastrostomy. The percentage of weight loss from diagnosis to gastrostomy was associated with mortality at 30, 90, and 180 days, highlighting the importance of nutritional care in the MND population. image
引用
收藏
页码:1010 / 1017
页数:8
相关论文
共 50 条
[21]   Investigation of the mitochondrial genome in patients with atypical motor neuron disease [J].
Phoenix, Catherine ;
Taylor, Geoffrey A. ;
Hartley, Judith ;
Nixon, Hannah ;
Ince, Paul G. ;
Shaw, Pamela J. ;
Turnbull, Douglass M. ;
Taylor, Robert W. .
JOURNAL OF NEUROLOGY, 2007, 254 (04) :482-487
[22]   Promoting palliative care in patients with motor neuron disease in Taiwan [J].
Wang, Pei-Ning .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (07) :361-362
[23]   Supporting people with Motor Neuron Disease (MND) to make decisions about gastrostomy feeding tube placement: a survey of UK healthcare professionals' practice and beliefs [J].
White, Sean ;
O'Cathain, Alicia ;
Halliday, Vanessa ;
Bradburn, Michael ;
McDermott, Christopher J. .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2024, 25 (3-4) :290-298
[24]   Gastrostomy use in motor neurone disease (MND): A review, meta-analysis and survey of current practice [J].
Stavroulakis, Theocharis ;
Walsh, Theresa ;
Shaw, Pamela J. ;
McDermott, Christopher J. .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 (02) :96-104
[25]   Treatment of respiratory impairment in patients with motor neuron disease in the Netherlands: patient preference and timing of referral [J].
Raaphorst, J. ;
Tuijp, J. ;
Verweij, L. ;
Westermann, E. J. A. ;
van der Kooi, A. J. ;
Gaytant, M. A. ;
van den Berg, L. H. ;
de Visser, M. ;
Kampelmacher, M. J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (12) :1524-1530
[26]   A Standardized Post-gastrostomy Feeding Protocol for Pediatric Patients Reduces Time to Postoperative Goal Feeding Volume [J].
O'Guinn, MaKayla L. ;
Keane, Olivia A. ;
Lee, William G. ;
Gayer, Christopher P. ;
Zobel, Michael J. .
AMERICAN SURGEON, 2024, 90 (10) :2600-2608
[27]   Progression and survival of patients with motor neuron disease relative to their fecal microbiota [J].
Ngo, Shyuan T. ;
Restuadi, Restuadi ;
McCrea, Allan F. ;
Van Eijk, Ruben P. ;
Garton, Fleur ;
Henderson, Robert D. ;
Wray, Naomi R. ;
McCombe, Pamela A. ;
Steyn, Frederik J. .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2020, 21 (7-8) :549-562
[28]   Improved survival and 30-day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria [J].
Gorrie, George H. ;
Chandran, Siddharthan ;
Colville, Shuna ;
Newton, Judith ;
Leighton, Danielle ;
Mcdonald, Menai ;
Pal, Suvankar ;
Forbes, Raeburn ;
Hair, Mario ;
Swingler, Robert .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2019, 20 (3-4) :165-171
[29]   A qualitative meta-synthesis of evidence (meta-ethnography) exploring the personal experiences of gastrostomy tube in neurodegenerative diseases: a case of motor neurone disease [J].
Lisiecka, Dominika ;
Kearns, Aine ;
Bourke, Fiona ;
Lawson, Ian ;
Muir, Cath .
DISABILITY AND REHABILITATION, 2022, 44 (18) :4949-4965
[30]   Electrodiagnostic Assessment of Motor Neuron Disease [J].
Kang, Xuan ;
Quan, Dianna .
NEUROLOGIC CLINICS, 2021, 39 (04) :1071-1081